A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
Trending
- Imo invests in robotics, oncology to curb medical tourism – Uzodimma
- FUD physics student develops AI-powered fire detection system
- Nigeria’s forex reserves hit $52.5bn, highest in 17 years — CBN
- IFAD-VCDP urges LGAs to form maintenance committees for farm infrastructure
- Malaria kills up to 700,000 annually in Sub-Saharan Africa – Abiru
- Lagos rain gear sellers count losses amid dry spells, August break
- AFAN Ogun seeks greater farmer inclusion in govt programmes
- Ex-UITH pharmacist urges continuous learning for better care
